Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma
oleh: Anne Lok, Julie Mocquard, Jessie Bourcier, Laurence Redelsperger, Antoine Bonnet, Cecile Chauvin, Patrick Thomaré, Beatrice Mahé, Cyrille Touzeau, Philippe Moreau
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2014-03-01 |
Deskripsi
No description available for this item.